SAB Biotherapeutics Leads The Pack Of 3 US Penny Stocks To Consider [Yahoo! Finance]
SAB Biotherapeutics, Inc. (SABS)
Company Research
Source: Yahoo! Finance
As the United States stock market navigates a complex landscape of inflation data and interest rate adjustments, investors are exploring diverse opportunities across various sectors. The term 'penny stocks' may seem outdated, but these smaller or newer companies can still offer potential for growth when they possess strong financial fundamentals. In this article, we explore three U.S. penny stocks that stand out for their financial resilience and potential to deliver value to investors seeking to uncover promising opportunities in the market. Top 10 Penny Stocks In The United States Name Share Price Market Cap Financial Health Rating QuantaSing Group (NasdaqGM:QSG) $99.16M ?????? Inter & Co (NasdaqGS:INTR) $1.91B ?????? BAB (OTCPK:BABB) $6.46M ?????? Pangaea Logistics Solutions (NasdaqCM:PANL) $227.01M ?????? ZTEST Electronics (OTCPK:ZTST.F) $7.76M ?????? Imperial Petroleum (NasdaqCM:IMPP) $86.14M ?????? Golden Growers Cooperative (OTCP
Show less
Read more
Impact Snapshot
Event Time:
SABS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SABS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SABS alerts
High impacting SAB Biotherapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
SABS
News
- SAB Biotherapeutics Third Quarter 2024 Earnings: US$1.12 loss per share (vs US$0.97 loss in 3Q 2023) [Yahoo! Finance]Yahoo! Finance
- SAB Biotherapeutics, Inc. (NASDAQ: SABS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $25.00 price target on the stock.MarketBeat
- SAB BIO Announces Third Quarter 2024 Financial Results and Provides Company UpdateGlobeNewswire
- SAB BIO CEO to Participate in Fireside Chat at Guggenheim Securities Healthcare Innovation ConferenceGlobeNewswire
- SAB Biotherapeutics, Inc. (NASDAQ: SABS) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $11.00 price target on the stock.MarketBeat
SABS
Earnings
- 11/6/24 - Miss
SABS
Sec Filings
- 11/6/24 - Form 10-Q
- 11/5/24 - Form 4
- SABS's page on the SEC website